Clinical Trial Update: Longitudinal Surveillance Study of the 4-SITE Lead/Header System

View source ↗

Summary

A completed longitudinal surveillance study of the 4-SITE Lead/Header System, with results posted in 2021, focusing on primary and secondary prevention of sudde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Cardiac Arrest

Drugs mentioned

• 4-SITE Lead/Header System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Primary Prevention of Sudden Cardiac Arrest, Secondary Prevention of Sudden Cardiac Arrest | Status: COMPLETED | Results posted: 2021-02-21